Researchers at Rush University Medical Center followed 3,099 older community-dwelling adults (average age 78, three-quarters women) over several years, measuring loneliness, social isolation, depression, and the severity of parkinsonism (the umbrella term for Parkinson's-like motor problems — slowness, stiffness, balance difficulty) at annual check-ups. After participants died, 846 brains were examined for Lewy bodies, the abnormal protein clumps that are the hallmark of Parkinson's disease. This is a large, longitudinal observational study — it tracks real people over time rather than running a lab experiment, so it can show associations but cannot alone prove that loneliness causes faster decline.
The headline finding: loneliness predicted both worse parkinsonism at any given moment and a faster rate of motor deterioration over time. The reverse was also true — people with more severe motor symptoms tended to feel lonelier — but that direction was weaker: worse parkinsonism raised loneliness scores, yet didn't independently speed up how fast loneliness grew. Among those whose brains showed Lewy body pathology at autopsy, the loneliness–motor-worsening link was even stronger than in those without it, suggesting the relationship may be particularly tight in people with true Parkinson's disease rather than other causes of parkinsonism. Crucially, the loneliness effect held up even after the researchers statistically accounted for depression and social isolation — meaning loneliness is not simply a proxy for either of those.
For someone living with Parkinson's or caring for them, this study adds to a growing body of evidence that feeling subjectively disconnected from others is not just emotionally painful — it may be a genuine factor in how fast motor symptoms worsen. It does not yet prove that treating loneliness will slow the disease, and no clinical guidance has changed as a result of this single study. But the finding is large enough, and the dataset robust enough, to justify discussing social connectedness with your neurologist or care team as a priority — not just quality-of-life 'soft' stuff, but potentially relevant to disease trajectory. Interventions that reduce loneliness (support groups, befriending programmes, community exercise classes) are low-risk and worth pursuing.